First prospective, randomized study to confirm the hypothesis that high postprandial glucose levels contribute to cardiovascular disease.

A synthetic form of “good cholesterol” has been shown to quickly shrink blockages clogging coronary arteries, offering for the first time the possibility of a drug that could actually rapidly reverse heart disease.

Latest COMET Trial Data Stir Continued Debate on Comparison

Two analyses now show that 80%-90% of CHD patients—and 95% of those with fatal CHD events—have at least one of four major risk factors (smoking, hypertension, high cholesterol, or diabetes).

More than one in four people with controlled diabetes are affected by slow passage of food out of the stomach into the intestines. Many diabetics also experience common symptoms of indigestion. However, the two conditions are not related.

A new no-calorie fat substitute is being tested in several food laboratories, and the product’s maker hopes it could eventually be used to slash calories in everything from cookies to burgers.

Diabetics improve chances of survival after a heart attack if they take a ACE inhibitor.

Screening of patients who have type 1 insulin dependent diabetes mellitus (IDDM1) for an immunoglobulin G 1 (IgG1) isotype serum antiendomysial antibody (IgG1 EMA) doubles the number of cases of coeliac disease (CD) that can be detected.

Weight management may be the most important therapy for obese individuals with type 2 diabetes, according to a recent American review.

Resistance training added to aerobic training significantly improved glucose disposal in postmenopausal obese type 2 diabetics.